Potential of the gastric motility drug lorglumide in prostate cancer imaging-Reference-Cited by-同舟云学术

Potential of the gastric motility drug lorglumide in prostate cancer imaging

Published:2012-04 Issue:5 Volume:45 Page:575-580
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Sturzu Alexander,Sheikh Sumbla,Klose Uwe,Echner Hartmut,Kalbacher Hubert,Deeg Martin,Nägele Thomas,Horger Marius,Schwentner Christian,Ernemann Ulrike,Heckl Stefan

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference18 articles.

1. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer;Catalona;N. Engl. J. Med.,1991

2. Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging;Deserno;Radiology,2004

3. Prostate-specific antigen testing and prostate cancer screening;Djavan;Prim. Care,2010

4. Selective CCK-A but not CCK-B receptor antagonists inhibit HT-29 cell proliferation: synergism with pharmacological levels of melatonin;González-Puga;J. Pineal. Res.,2005

5. Ferumoxtran-10-enhanced MR lymphangiography: does contrast-enhanced imaging alone suffice for accurate lymph node characterization?;Harisinghani;Am. J. Roentgenol.,2006

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peptide-based long-acting co-agonists of GLP-1 and cholecystokinin 1 receptors as novel anti-diabesity agents;European Journal of Medicinal Chemistry;2022-04

2. A Cholecystokinin B Receptor-Specific DNA Aptamer for Targeting Pancreatic Ductal Adenocarcinoma;Nucleic Acid Therapeutics;2017-02

3. Recent Advances in the Nanotechnology-Based Drug Delivery of Silybin;Journal of Biomedical Nanotechnology;2014-04-01